{
    "code": "02017213",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02017213",
    "time": "2020-02-25 11:33:52",
    "許可證字號": "衛署藥輸字第017213號",
    "註銷狀態": "已註銷",
    "註銷日期": "98\/12\/31",
    "註銷理由": "屆期未申請展延",
    "製造許可登錄編號": "",
    "有效日期": "93\/10\/03",
    "發證日期": "78\/05\/16",
    "許可證種類": "製　劑",
    "舊證字號": "02016056",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201721302",
    "中文品名": "麻佳因腎上腺素注射液０．５％",
    "英文品名": "MARCAINE ADRENALINE INJECTION 0.5%",
    "適應症": "局部麻醉",
    "劑型": "270注射劑",
    "包裝": "小瓶",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "EPINEPHRINE (BITARTRATE), BUPIVACAINE HCL (MONOHYDRATE)",
    "限制項目": "02輸　入",
    "申請商名稱": "1434901100  臺灣阿斯特捷利康股份有限公司",
    "申請商地址": "台北巿敦化南路二段２０７號２１樓",
    "主製造廠": [
        {
            "製造廠名稱": "FSE0022000  ASTRAZENECA AB",
            "製造廠廠址": "S-151 85 SODERTALJE  SWEDEN",
            "製造廠公司地址": "",
            "製造廠國別": "SWEDEN",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1212009620",
            "成分名稱": "EPINEPHRINE (BITARTRATE)",
            "含量描述": "(10.00UG) 5.50",
            "含量": "",
            "單位": "MCG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "7200008216",
            "成分名稱": "BUPIVACAINE HCL (MONOHYDRATE)",
            "含量描述": "(5.28MG) 5.00",
            "含量": "",
            "單位": "MG"
        }
    ]
}